The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation
- PMID: 31812666
- DOI: 10.1016/j.bbadis.2019.165632
The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation
Abstract
LRRK2 and SNCA, the gene for α-synuclein, are the two of the most important genetic factors of Parkinson's disease (PD). A-synuclein is aggregated and accumulated in neurons and glia in PD and considered the pathogenic culprit of the disease. A-synuclein aggregates spread from a few discrete regions of the brain to larger areas as the disease progresses through cell-to-cell propagation mechanism. LRRK2 is involved in the regulation of vesicle trafficking, in particular in the endolysosomal and autophagic pathways. Studies also suggest that LRRK2 might regulate the pathogenic actions of α-synuclein. However, the relationship between these two proteins in the pathogenesis of PD remains elusive. Here, we review the current literature on the pathophysiological function of LRRK2 with an emphasis on its role in the endolysosomal and autophagic pathways. We also propose a potential mechanism by which LRRK2 is involved in the regulation of aggregation and the propagation of α-synuclein.
Keywords: LRRK2; Parkinson's disease; Protein aggregation; Vesicle trafficking; α-Synuclein.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.Neurobiol Dis. 2018 Mar;111:26-35. doi: 10.1016/j.nbd.2017.12.005. Epub 2017 Dec 12. Neurobiol Dis. 2018. PMID: 29246723 Free PMC article.
-
Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).Autophagy. 2020 Feb;16(2):347-370. doi: 10.1080/15548627.2019.1603545. Epub 2019 Apr 14. Autophagy. 2020. PMID: 30983487 Free PMC article.
-
Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11. Adv Neurobiol. 2017. PMID: 28353286 Review.
-
LRRK2 and the Endolysosomal System in Parkinson's Disease.J Parkinsons Dis. 2020;10(4):1271-1291. doi: 10.3233/JPD-202138. J Parkinsons Dis. 2020. PMID: 33044192 Free PMC article. Review.
-
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation.Nat Commun. 2018 Aug 27;9(1):3465. doi: 10.1038/s41467-018-05958-z. Nat Commun. 2018. PMID: 30150626 Free PMC article.
Cited by
-
Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson's disease related transcriptional profile and function.Sci Rep. 2023 Dec 13;13(1):22118. doi: 10.1038/s41598-023-49294-9. Sci Rep. 2023. PMID: 38092815 Free PMC article.
-
In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's disease.Brain. 2025 Jun 3;148(6):2075-2092. doi: 10.1093/brain/awae404. Brain. 2025. PMID: 39705401 Free PMC article.
-
Leucine-rich repeat kinase 2 at a glance.J Cell Sci. 2023 Sep 1;136(17):jcs259724. doi: 10.1242/jcs.259724. Epub 2023 Sep 12. J Cell Sci. 2023. PMID: 37698513 Free PMC article.
-
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.Nat Commun. 2023 Jun 20;14(1):3651. doi: 10.1038/s41467-023-39038-8. Nat Commun. 2023. PMID: 37339976 Free PMC article.
-
The Emerging Role of the Lysosome in Parkinson's Disease.Cells. 2020 Nov 2;9(11):2399. doi: 10.3390/cells9112399. Cells. 2020. PMID: 33147750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous